Semarion has secured new funding to expand its cell-based drug discovery platform, supporting manufacturing scale-up, ...

Performance driven by core drug discovery, continued adoption in environmental toxicology, and launch of new assays and ...

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Symeres, Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer: Nijmegen, Netherlands Thursday, April 2, 2026, 12:00 Hrs [IST] Symeres, a leading CRDMO ...

UK biotech Semarion has secured $3.8 million (£2.9 million) to expand manufacturing and commercial reach of its cell-based ...

Eurofins Viracor, a leader in advanced clinical diagnostics, today announced the launch of the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the ...

Scientists at Oregon Health & Science University have uncovered a previously unknown system of internal "trade winds" that ...

Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are characterized by the abnormal aggregation of pathological proteins ...

As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...